Literature DB >> 8586522

Response of serum angiotensin converting enzyme, plasma renin activity and plasma aldosterone to conventional dialysis in patients on chronic haemodialysis.

C Letizia1, S Mazzaferro, S Morabito, A De Ciocchis, S Cerci, C D'Ambrosio, G A Cinotti, D Scavo.   

Abstract

The aim of this study was to examine serum angiotensin converting enzyme (SACE) activity and the renin-angiotensin-aldosterone system in patients on chronic haemodialysis during one routine dialysis session. Fourteen patients (8 men and 6 women; mean age 51.9 +/- 17 years) with end stage renal disease, receiving regular haemodialysis treatment for an average of 6 months, were studied. The patients were dialysed for 4 hours three times a week using cellulose membranes (cuprophan). After an overnight fast blood samples were taken from the patients before and after the haemodialysis session. Serum and plasma were separated and stored at -20 degrees C until assayed for SACE, plasma renin activity (PRA) and plasma aldosterone (PA). For comparison, SACE, PRA and PA were also measured in 8 patients after renal allotransplantation and on treatment with cyclosporin A (5 men, 3 women; mean age 38.9 +/- 12.3 years) and in 19 healthy subjects (13 men, 6 women; mean age 38.9 +/- 12.3 years). SACE levels in patients with chronic renal failure and on haemodialysis (17.55 +/- 9.03 nmol/ml/min) and in patients with renal transplantation (18.12 +/- 3.92) were significantly higher than those of the healthy subjects (9.27 +/- 1.67) (p < 0.0001, respectively). At the end of the dialysis session SACE levels in patients with chronic renal failure (14.9 +/- 7.19) did not increase in respect to pre-dialysis levels (17.55 +/- 9.03; p = 0.132). PRA and PA values increased after the dialysis session (p < 0.026 and p < 0.044, respectively). Correlation of SACE with PRA and PA was not demonstrated before or after the dialysis session. In patients with chronic renal failure and on haemodialysis our findings suggest that a disarrangement exists between the circulatory components of the reninangiotensin-aldosterone system before and after the dialysis session.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8586522     DOI: 10.1007/bf02550085

Source DB:  PubMed          Journal:  Int Urol Nephrol        ISSN: 0301-1623            Impact factor:   2.370


  19 in total

1.  Elevation of serum angiotensin-converting enzyme in Gaucher's disease.

Authors:  J Lieberman; E Beutler
Journal:  N Engl J Med       Date:  1976-06-24       Impact factor: 91.245

2.  The angiotensin I converting enzyme.

Authors:  E G Erdös
Journal:  Fed Proc       Date:  1977-04

3.  Application of a radioimmunoassay for angiotensin I to the physiologic measurements of plasma renin activity in normal human subjects.

Authors:  E Haber; T Koerner; L B Page; B Kliman; A Purnode
Journal:  J Clin Endocrinol Metab       Date:  1969-10       Impact factor: 5.958

4.  Simplified radioimmunoassay for serum aldosterone utilizing increased antibody specificity.

Authors:  J K McKenzie; J A Clements
Journal:  J Clin Endocrinol Metab       Date:  1974-04       Impact factor: 5.958

5.  Angiotensin-converting enzyme activity in myocardial ischemia during exercise testing.

Authors:  C Letizia; F Barillà; S Cerci; P P Campa; D Scavo
Journal:  Am Heart J       Date:  1993-03       Impact factor: 4.749

6.  Serum angiotensin-converting enzyme increases during hemodialysis. Evidence for injury of the pulmonary vascular endothelium?

Authors:  A H Nielsen; F Knudsen; S D Kristensen
Journal:  Nephron       Date:  1985       Impact factor: 2.847

7.  Angiotensin I converting enzyme activity in hypertension. Relationship to blood pressure, renin-sodium profiles, and antihypertensive therapy.

Authors:  A P Niarchos; L M Resnick; D L Weinstein; J H Laragh
Journal:  Am J Med       Date:  1985-10       Impact factor: 4.965

8.  Increased angiotensin-converting enzyme activities in diabetes mellitus: analysis of diabetes type, state of metabolic control and occurrence of diabetic vascular disease.

Authors:  G Schernthaner; C Schwarzer; R Kuzmits; M M Müller; U Klemen; H Freyler
Journal:  J Clin Pathol       Date:  1984-03       Impact factor: 3.411

9.  Angiotensin-converting enzyme activity in renal disorders: influence of disease pattern, hemodialysis and transplantation.

Authors:  F K Rømer; O Schmitz
Journal:  Clin Nephrol       Date:  1984-03       Impact factor: 0.975

10.  Serum angiotensin converting enzyme in diabetic retinopathy.

Authors:  C Letizia; P Repossi; M Sellini; S Cerci; G Santi; A M De Negri; M Pannarale; D Scavo
Journal:  Int J Tissue React       Date:  1992
View more
  3 in total

Review 1.  A case of normoreninemic aldosterone-producing adenoma associated with chronic renal failure: case report and literature review.

Authors:  Hiroyuki Koshiyama; Takeshi Fujisawa; Naomitsu Kuwamura; Yoshio Nakamura; Hiroshi Kanamori; Emi Oida; Akira Hara; Takashi Suzuki; Hironobu Sasano
Journal:  Endocrine       Date:  2003-08       Impact factor: 3.633

Review 2.  Possible benefits of exogenous melatonin for individuals on dialysis: a narrative review on potential mechanisms and clinical implications.

Authors:  Seyed Majid Mousavi Movahhed
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2021-06-07       Impact factor: 3.000

Review 3.  Some Aspects of the Renin-Angiotensin-System in Hemodialysis Patients.

Authors:  Umar Malik; Veena Raizada
Journal:  Kidney Blood Press Res       Date:  2015-11-29       Impact factor: 2.687

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.